J. Norfleet

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

R. McLendon, A. Friedman, D. Bigner, 2009, British Journal of Cancer.

Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.

H. Friedman, D. Reardon, M. Linskey, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

R. McLendon, H. Friedman, D. Reardon, 2012, Journal of Neuro-Oncology.

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

R. McLendon, P. Wen, A. Norden, 2011, Journal of Neuro-Oncology.

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma.

R. McLendon, H. Friedman, D. Reardon, 2010, Neuro-oncology.

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

R. McLendon, H. Friedman, D. Reardon, 2009, Journal of Neuro-Oncology.

Phase II trial of bevacizumab plus erlotinib for patients with recurrent malignant gliomas: Final results.

R. McLendon, H. Friedman, D. Reardon, 2010 .

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

R. McLendon, D. Bigner, H. Friedman, 2009, British Journal of Cancer.